申请人:SmithKline Beecham Corporation
公开号:US05393788A1
公开(公告)日:1995-02-28
Novel oxamide derivatives are described which inhibit the production of TNF and are useful in the treatment of disease states mediated or exacerbated by TNF production. The compounds of the present invention are also useful as inhibitors of PDE IV and are therefor useful in the treatment of disease states mediated or exacerbated thereby.
描述了一种新型的草酰胺衍生物,它们抑制TNF的产生,并且在治疗由TNF产生介导或加重的疾病状态中具有用处。本发明的化合物还可作为PDE IV的抑制剂,因此在治疗由此介导或加重的疾病状态中也具有用处。